Moffitt Cancer Center Logo
 

Mihaela Druta, MD

Where You Are:

Mihaela Druta, MD

Medical Oncology

 
 

BOARD CERTIFICATION:
          •  Internal Medicine,Hematology (eligible)

          •  Internal Medicine,Medical Oncology (eligible)

FELLOWSHIP:
          •  MD Anderson Cancer Center - Sarcoma Medical Oncology
          •  H. Lee Moffitt Cancer Center - Hematology and Medical Oncology

RESIDENCY:
          •  University of South Florida - Internal Medicine

MEDICAL SCHOOL:
          •  University of Medicine and Pharmacy Carol Davilla - MD

  • Liu JJ, Druta M, Shibata D, Coppola D, Boler I, Elahi A, Reich RR, Siegel E, Extermann M. Metabolic syndrome and colorectal cancer: Is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?. J Geriatr Oncol. 2014 Jan;5(1):40-48. Pubmedid: 24484717.

  • Liu JJ, Druta M, Shibata D, Coppola D, Boler I, Elahi A, Reich RR, Siegel E, Extermann M. Metabolic Syndrome and Colorectal Cancer: Is hyperinsulinemia/Insulin Receptor-Mediated Angiogenesis a Critical Process?. J Geriatr Oncol. 2013 Dec.

Dr. Druta earned her MD degree from the University of Medicine and Pharmacy Carol Davila, Romainia.  She completed an Internal Medicine Residency and Hematology/Medical Oncology Fellowship at the University of South Florida at Moffitt Cancer Center.  Dr. Druta most recently completed a Sarcoma Medical Oncology Fellowship (Willie Tichenor Sarcoma Fellowship) at MD Anderson Cancer Center.

Dr. Druta's clinical interest is in the development of clinical trials focusing on targeted therapeutics specific to sarcoma patients.  Her research interest is in the translational aspects of sarcoma biology focusing specifically on Well-differentiated/Differential Liposarcoma and Leiomyosarcoma.